tirzepatide crohn's Mirikizumab and Administered in Adult Participants With Moderately to Severely Active Disease and Obesity or Overweight (COMMIT-CD) Tirzepatide & Crohn's Disease: Safe

Wayne, NJ: Bayer HealthCare Pharmaceuticals Inc

The goal is nutritional optimization during therapy, not competing mechanisms

Tirzepatide works by increasing insulin secretion, reducing glucagon (a hormone that raises blood sugar), and slowing down the emptying of food from the stomach, which helps to lower blood sugar levels after a meal

The 10-second hold allows the full dose to leave the pen cartridge and deposit into the tissue

This #partnership fosters a #holistic approach to weight loss and leads to achieving #sustainable results

Important caveats include program enrollment rules, manufacturer participation, and timing of payer formulary updates that may delay savings for some patients